DGCI approves market authorisation of Serum Institute’s Covovax as booster dose January 17, 2023 by Asian News International
Corbevax recommended as booster for adults vaccinated with Covishield, Covaxin August 2, 2022 by Press Trust of India
Hyderabad based Corbevax gets DGCI nod as COVID-19 booster for 18+ June 4, 2022 by Indo-Asian News Service
SII, Bharat Biotech cut prices of COVID-19 vaccines for pvt hospitals to Rs 225 April 9, 2022 by Press Trust of India
Covid precaution dose for 18+ age group at private vaccination centres from Apr 10 April 9, 2022 by Press Trust of India
Serum Institute’s Covishield precaution dose priced at Rs 600 per shot April 8, 2022 by Press Trust of India
Regular market approval granted for Covishield, Covaxin for use in adult population January 27, 2022 by Press Trust of India
One year on, vaccines still most acceptable weapon against COVID-19 January 16, 2022 by Press Trust of India
Over 14.84 cr unutilized COVID-19 vaccine doses still available with States, UTs: Centre January 15, 2022 by Asian News International
DCGI to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today January 14, 2022 by Indo-Asian News Service
SII applies to Indian authorities for full market authorisation of Covishield December 31, 2021 by Press Trust of India
110 countries recognise India’s Covishield, Covaxin: Source November 19, 2021 by Indo-Asian News Service
India, UK hold talks on vaccine certification process: British envoy September 23, 2021 by Press Trust of India
Expert panel recommends trials on mixing Covaxin and Covishield July 30, 2021 by Asian News International
Vaccines effective in reducing mortality by 50% in Delta variant patients : CCMB July 18, 2021 by Nikita Venkatesh
Covishield recognised by 16 European nations: SII’s Adar Poonawalla July 18, 2021 by Asian News International
